Oracle announced the availability of Oracle Argus Safety 7.0, an integrated global adverse events (AE) management and regulatory reporting solution.
The newest release enables health sciences organizations and contract research organizations (CROs) to maintain separation among and securely manage safety data from firms across the complex network of customers and business partners required for product development in the health sciences industry. Thisapproach eliminates the operational requirements and IT costs associated with setting up and managing several instances of a traditional safety solution in an enterprise, while maintaining stringent security controls and facilitating compliance with US Food & Drug Administration (FDA) 21 CFR Part 11 electronic record and signature requirements.
"Product development in the health sciences industry is increasingly virtualized and complex, often spanning the globe and requiring the management of safety data from numerous co-marketing, in-licensing, and partner entities," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. "Health sciences enterprises and their partners seek secure and efficient ways to manage this data across partners."
Oracle Argus Safety 7.0 also features new capabilities, such as standardized configurations and rules management, as well as centralized coding-dictionary management, all of which enable rapid set up and maintenance of new safety datasets, regardless of their source. In addition, the solution reduces the resources required for ongoing maintenance through a single, global user management and administration tool. With its new extensible portal, Oracle Health Sciences Argus Safety 7.0 also helps organizations establish and manage organizational safety priorities appropriately across all products and stakeholders from a single interface. The solution's role-based workflows and work lists help ensure that users are aware of overall priorities and focused on the most critical events.
Oracle Argus Safety 7.0 is part of Oracle's set of comprehensive solutions to manage pharmacovigilance, signal detection and proactive risk management across the product lifecycle.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.